Mobile phase optimisation for oligonucleotide analytical methods by LC-MS
ABOUT THIS WEBINAR
The use of alkylamine ion pair and perfluorinated alcohols in the analysis of oligonucleotides by LC-MS techniques has been the mainstay in characterisation and quantitation methods for synthetic oligonucleotides for decades. Often, analytical chemists default to relatively high concentrations of both, but how much ion pair is needed for optimal chromatographic performance and how much does perfluorinated alcohol concentration contribute to electrospray ionisation efficiency?
In this on-demand, we provide an overview of nucleic acid therapeutics and discuss the chromatographic challenges associated with oligonucleotides. We also explore modulation of the mobile phase additives alkylamine ion pair and perfluorinated alcohols. Finally, we will show how optimisation of mobile phase can improve not only chromatographic performance and MS sensitivity, but may also directly impact MS data acquisition, thus facilitating data analysis.
Learning outcomes of this webinar:
Biomarkers aren’t just supporting drug discovery – they’re driving it
FREE market report
From smarter trials to faster insights, this report unpacks the science, strategy and real-world impact behind the next generation of precision therapies.
What you’ll unlock:
- How biomarkers are guiding dose selection and early efficacy decisions in complex trials
- Why multi-omics, liquid biopsy and digital tools are redefining the discovery process
- What makes lab data regulatory-ready and why alignment matters from day one
Explore how biomarkers are shaping early drug development
Access the full report – it’s free!
- An overview of nucleic acid therapeutics
- The chromatographic challenges associated with oligonucleotides
- Method development considerations for oligonucleotide analysis by LC
- The role of mobile phase and column chemistry in LC-MS methods for oligonucleotides
- How to improve overall method robustness and sensitivity for oligonucleotide method development.
KEYNOTE SPEAKER
Brian Rivera, Senior Product Manager, Phenomenex
Brian Rivera is currently the Product Manager for Bioseparations Products at Phenomenex, Incorporated, Torrance, California, US. Prior to this role, Brian has held a variety of positions in sales and marketing related to biotechnology products. He worked as a Technical Sales Specialist for Phenomenex and Eppendorf, an Account Manager for ProZyme and a Biotechnology Product Specialist for Phenomenex. Prior to his business-facing roles, Brian worked in analytical methods development and in manufacturing support roles for a few biotechnology companies in the San Francisco Bay Area; including Avid Bioservices, ProZyme and Chiron Corporation. He has a bachelor’s degree from the University of California, Davis.
Related topics
Analysis, Analytical Techniques, Biopharmaceuticals, Disease Research, Gene Testing, Genetic Analysis, Genome Editing, Genomics, Mass Spectrometry, Personalised Medicine
Related organisations
Phenomenex
